Antibody Production Tailored to Your Specific Field

evitria supports diverse research communities with tailored antibody production services.

Our CHO-based platform delivers reproducible, high-quality antibodies for academic research, government programs, and therapeutic development – each solution is designed to meet the specific requirements, timelines, and standards of your research environment.

applications therapy development high specific antibodies

ANTIBODY THERAPEUTIC DEVELOPMENT

Solutions for Biotech and Pharmaceutical Teams in Therapeutic Development

High-stakes candidate selection requires decision-grade data that not only supports early discovery, but also predicts manufacturability, scalability, and long-term stability.

  • Focus: Rapid generation of robust, decision-relevant data to support critical R&D milestones
  • Value: High-quality recombinant antibody expression in CHO cells, ensuring reproducibility and minimizing scientific and
    translational risk
  • Impact: Accelerated and de-risked program progression toward funding, partnering, and preclinical milestones

Academic research

Support for Academic Research Institutions

Reliable antibody production ensures that laboratory research remains reproducible, consistent, and suitable for high-impact publications and future grant funding.
Our CHO-based expression platform provides the stability required for
long-term research success.

  • Focus: Experimental validity for grant-funded projects and
    peer-reviewed publications
  • Value: Consistent, reproducible results within strict grant-driven
    budget constraints
  • Impact: Reduced risk of failed experiments, protecting publication outcomes and funding timelines
Antibody Production for Academic Research
Antibody Expression for National Research Programs

national research programs

Antibody Production for Government Research Programs

Public health initiatives require the highest level of robustness and clear, reliable documentation to ensure project success.

  • Focus: High reliability for complex and high-stakes research programs
  • Value: Consistent antibody production supported by transparent and well-structured documentation
  • Impact: Reduced variability through consistent batch-to-batch reproducibility, supporting confidence in research outcomes

Let’s get in touch with our experts now!

Bradley Gartland evitria
Jürgen Lübbehusen evitria